Protalix BioTherapeutics, Inc. (DE) financial statements, including revenue, expenses, profit, and loss
The total revenue of PLX for the last quarter is 17.96 M USD, and it's 33.29% higher compared to the previous quarter. The net income of Q3 24 is 3.24 M USD.